1,225.14
-24.86
(-1.99%)
At close: January 31 at 2:53:22 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 19 | 6 | 25 | 25 |
| Avg. Estimate | 11.56B | 11.33B | 47.5B | 46.39B |
| Low Estimate | 11.31B | 10.81B | 47.27B | 45.18B |
| High Estimate | 11.78B | 11.71B | 47.75B | 47.82B |
| Year Ago Sales | 11.48B | 11.87B | 45.01B | 47.5B |
| Sales Growth (year/est) | 0.69% | -4.48% | 5.55% | -2.34% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BMY.MX | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Maintains | Citigroup: Neutral to Neutral | 1/28/2025 |
| Maintains | Truist Securities: Buy to Buy | 1/8/2025 |
| Upgrade | Jefferies: Hold to Buy | 12/16/2024 |
| Initiated | Wolfe Research: Peer Perform | 11/15/2024 |
| Maintains | Citigroup: Neutral to Neutral | 11/12/2024 |
| Maintains | BMO Capital: Market Perform to Market Perform | 11/12/2024 |